ALL MARKETS
FTSE 100
FTSE 250
AIM MARKET

SVNS.
34 announcements.
Time Date Ticker Company Announcement
07:00 23-06-2025 SVNS SVNS
Allowance of U.S. patent covering AI-supported CNS
07:30 11-06-2025 SVNS SVNS
Initiation of AI supported CNS drug discovery
07:00 05-06-2025 SVNS SVNS
Synthesis of development candidate for SVN-SDN-014
16:30 03-06-2025 SVNS SVNS
Notice of Annual General Meeting
07:00 03-06-2025 SVNS SVNS
Appointment of Prof. David Nutt as CSO
11:58 02-06-2025 SVNS SVNS
Holding(s) in Company
17:00 30-05-2025 SVNS SVNS
Total Voting Rights
15:11 29-05-2025 SVNS SVNS
Holding(s) in Company
12:02 29-05-2025 SVNS SVNS
Holding(s) in Company
10:30 29-05-2025 SVNS SVNS
Holding(s) in Company
07:00 29-05-2025 SVNS SVNS
Presentation at Mello2025
07:30 28-05-2025 SVNS SVNS
Holding(s) in Company
07:00 28-05-2025 SVNS SVNS
Completion of the acquisition of Awakn
15:24 21-05-2025 SVNS SVNS
Publication of a Prospectus
07:31 16-05-2025 SVNS SVNS
Result of placing
16:53 15-05-2025 SVNS SVNS
Proposed equity fundraising via ABB
11:30 28-04-2025 SVNS SVNS
Result of General Meeting
07:00 23-04-2025 SVNS SVNS
Proposed acquisition of Awakn approved
07:00 16-04-2025 SVNS SVNS
Final Results for the year ended 31 December 2024
14:00 10-04-2025 SVNS SVNS
Posting of Circular and Notice of General Meeting
07:00 07-04-2025 SVNS SVNS
Holding(s) in Company
07:00 04-04-2025 SVNS SVNS
Engagement of PharmaVentures
07:00 26-03-2025 SVNS SVNS
Positive progress on European Patent Application
07:00 18-03-2025 SVNS SVNS
Update on AWKN-SDN-14 programme
09:00 11-03-2025 SVNS SVNS
Holding(s) in Company
07:00 11-03-2025 SVNS SVNS
Appointment of Non-Executive Director
07:00 25-02-2025 SVNS SVNS
Presentation at PharmaSynergyRx Event
07:00 24-02-2025 SVNS SVNS
Entry into an Arrangement Agreement with Awakn
12:00 30-01-2025 SVNS SVNS
Proactive Investors interview with Chairman
07:00 27-01-2025 SVNS SVNS
Update on Awakn Life Sciences’ R&D Progress
07:00 24-01-2025 SVNS SVNS
Investor Presentation
14:29 21-01-2025 SVNS SVNS
Proactive Investors interview with CEO
07:00 21-01-2025 SVNS SVNS
Update on FDA Pre-IND Meeting for Awakn
07:00 15-01-2025 SVNS SVNS
Interview with CEO